{
  "id": 1767814725899,
  "title": "Thyroid Eye Disease: The OHOP Clinical Guide",
  "summary": "A comprehensive visual reference for Thyroid Eye Disease (TED), also known as Graves' Orbitopathy, based on the Oxford Handbook of Ophthalmology. This poster details the pathogenesis, clinical staging, and multisystem management of this sight-threatening autoimmune condition.",
  "date": "2026-01-07T19:38:45.899Z",
  "data": {
    "title": "Thyroid Eye Disease: The OHOP Clinical Guide",
    "summary": "A comprehensive visual reference for Thyroid Eye Disease (TED), also known as Graves' Orbitopathy, based on the Oxford Handbook of Ophthalmology. This poster details the pathogenesis, clinical staging, and multisystem management of this sight-threatening autoimmune condition.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='40' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M30 50 Q50 20 70 50 Q50 80 30 50' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><circle cx='50' cy='50' r='8' fill='hsl(215, 90%, 45%)'/><path d='M40 85 L50 75 L60 85' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><text x='50' y='95' font-size='6' text-anchor='middle' fill='hsl(215, 90%, 45%)' font-family='Arial'>Thyroid Orbitopathy</text></svg>",
    "sections": [
      {
        "title": "Epidemiology & Etiology",
        "icon": "groups",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Most common cause of orbital disease.",
          "Autoimmune process associated with dysthyroid states (usually Hyperthyroid/Graves').",
          "Female to Male ratio is approximately 5:1.",
          "Can occur in euthyroid or hypothyroid patients.",
          "Strongly associated with Smoking (increases risk and severity)."
        ]
      },
      {
        "title": "Pathogenesis: The Cellular Process",
        "icon": "biotech",
        "type": "process",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "1. TSH-receptor antibodies (TRAb) target orbital fibroblasts.",
          "2. Activation leads to Glycosaminoglycan (GAG) production (hyaluronic acid).",
          "3. Osmotic pressure increases, causing edema and tissue expansion.",
          "4. Adipogenesis (fatty hypertrophy) occurs.",
          "5. Late-stage fibrosis of extraocular muscles (EOMs)."
        ]
      },
      {
        "title": "Clinical Features Checklist",
        "icon": "checklist",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "center": "TED Symptoms",
          "branches": [
            "Eyelid: Retraction (Dalrymple’s sign), Lid lag (von Graefe’s sign), Edema",
            "Orbit: Proptosis (axial), Chemosis, Caruncle swelling",
            "EOM: Restrictive myopathy, Diplopia (worse in mornings)",
            "Optic Nerve: Reduced VA, RAPD, Color vision loss, Disc edema"
          ]
        }
      },
      {
        "title": "NOSPECS Classification (Werner's)",
        "icon": "reorder",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Grade",
            "Manifestation"
          ],
          "rows": [
            [
              "0",
              "N: No signs or symptoms"
            ],
            [
              "1",
              "O: Only signs (Lid retraction/stare)"
            ],
            [
              "2",
              "S: Soft tissue involvement (edema, chemosis)"
            ],
            [
              "3",
              "P: Proptosis (>20mm)"
            ],
            [
              "4",
              "E: Extraocular muscle involvement (diplopia)"
            ],
            [
              "5",
              "C: Corneal involvement (exposure keratitis)"
            ],
            [
              "6",
              "S: Sight loss (optic nerve compression)"
            ]
          ]
        }
      },
      {
        "title": "Clinical Activity Score (CAS)",
        "icon": "monitoring",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Pain: Spontaneous retrobulbar pain",
          "Pain on attempted upward or downward gaze",
          "Redness: Eyelid erythema",
          "Redness: Conjunctival injection (diffuse)",
          "Swelling: Chemosis",
          "Swelling: Swollen caruncle or plica",
          "Swelling: Eyelid edema",
          "Scoring: Active TED is defined as CAS ≥ 3/7 at first visit."
        ]
      },
      {
        "title": "Dysthyroid Optic Neuropathy (DON)",
        "icon": "report_problem",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "URGENT: Occurs in 5% of cases due to apical crowding.",
          "Decreased visual acuity (VA) or changed color vision.",
          "Relative Afferent Pupillary Defect (RAPD).",
          "Visual field defects (central or arcuate).",
          "Swollen or pale optic disc.",
          "Requires immediate High-dose IV Methylprednisolone or Decompression."
        ]
      },
      {
        "title": "Investigations",
        "icon": "science",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Thyroid Function Tests (TFTs): T3, T4, TSH.",
          "Autoantibodies: TRAb (highly specific), TPO, Anti-Tg.",
          "Imaging: CT or MRI of orbits (shows 'tendon-sparing' muscle belly enlargement).",
          "Formal Visual Fields (Humphrey) if DON suspected.",
          "Hertel Exophthalmometry: To measure proptosis."
        ]
      },
      {
        "title": "Order of Muscle Involvement",
        "icon": "fitness_center",
        "type": "remember",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "mnemonic": "I M S L",
          "explanation": "I: Inferior Rectus (most common), M: Medial Rectus, S: Superior Rectus, L: Lateral Rectus (least common)."
        }
      },
      {
        "title": "Management Strategy",
        "icon": "medical_services",
        "type": "process",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "1. General Measures: Smoking cessation (essential), achieve euthyroid state, lubrication (artificial tears).",
          "2. Active Phase (Medical): Oral/IV Steroids, Orbital Radiotherapy, or Immunosuppression (e.g., Ciclosporin, Mycophenolate).",
          "3. Emerging Therapies: Teprotumumab (IGF-1R inhibitor).",
          "4. Stable Phase (Surgical): Wait for 6-9 months of stability before rehabilitative surgery."
        ]
      },
      {
        "title": "Rehabilitative Surgical Hierarchy",
        "icon": "architecture",
        "type": "table",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "headers": [
            "Order",
            "Procedure Type",
            "Indications"
          ],
          "rows": [
            [
              "1st",
              "Orbital Decompression",
              "For proptosis or DON"
            ],
            [
              "2nd",
              "Strabismus Surgery",
              "For restrictive diplopia (e.g., Recession)"
            ],
            [
              "3rd",
              "Eyelid Surgery",
              "For lid retraction or blepharoplasty"
            ]
          ]
        }
      },
      {
        "title": "The Rundle's Curve Concept",
        "icon": "trending_up",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "TED follows a predictable course described by Rundle's Curve: An initial active inflammatory phase of worsening (months to 2 years) followed by a plateau and a slow natural improvement (burn-out). However, the patient rarely returns to the pre-disease baseline without surgical intervention. Treatment should match the phase: aggressive anti-inflammatories during the 'slope' and surgery during the 'plateau'."
      }
    ]
  },
  "chapterId": "orbit",
  "seqId": 52,
  "_serverSynced": true
}